Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 / 抑制剂/激动剂 / 抗感染 /
艾滋病病毒
NNRTI
/ Delavirdine/地拉韦啶

Delavirdine/地拉韦啶 {[allProObj[0].p_purity_real_show]}

货号：A705540 同义名： U 90152; BHAP-U 90152

Delavirdine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine/地拉韦啶 化学结构 CAS号：136817-59-9
Delavirdine/地拉韦啶 化学结构
CAS号：136817-59-9
Delavirdine/地拉韦啶 3D分子结构
CAS号：136817-59-9
Delavirdine/地拉韦啶 化学结构 CAS号：136817-59-9
Delavirdine/地拉韦啶 3D分子结构 CAS号：136817-59-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Delavirdine/地拉韦啶 纯度/质量文件 产品仅供科研

货号：A705540 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

更多 >

Delavirdine/地拉韦啶 生物活性

描述 Delavirdine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI).

Delavirdine/地拉韦啶 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00197145 Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << Phase 3 Terminated - -
NCT02016924 Acquired Immune Deficiency Syn... 展开 >>drome (AIDS) HIV Infections 收起 << Phase 2 Phase 3 Recruiting December 2024 United States, California ... 展开 >> Pediatric Infectious Diseases Associate Recruiting Long Beach, California, United States, 90806 Principal Investigator: Jagmohan Batra, MD          Children's Hospital Los Angeles Withdrawn Los Angeles, California, United States, 90027 United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Principal Investigator: Elizabeth McFarland, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20852 Principal Investigator: Natella Rakhmanina          United States, Florida University of South Florida Clinic at Children's Medical Services Recruiting Tampa, Florida, United States, 33620 Principal Investigator: Carina Rodriguez, MD          United States, Georgia Emory-Children's Center- Ponce Family and Youth Clinic Completed Atlanta, Georgia, United States, 30308 United States, Massachusetts Boston Medical Center Withdrawn Boston, Massachusetts, United States, 02118 United States, New York Bellevue Hospital Recruiting New York, New York, United States, 10016 Principal Investigator: William Borkowsky, MD          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Principal Investigator: Leonard Weiner, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Principal Investigator: Aditya Gaur, MD          United States, Texas University of Texas Health Science Center of Houston Recruiting Houston, Texas, United States, 77030 Principal Investigator: Gloria Heresi, MD          Argentina Hospital General de Agudos Dr. Cosme Argerich Recruiting Buenos Aires, Argentina, 1151 Principal Investigator: Diego Cecchini          Helios Salud S.A. Recruiting Buenos Aires, Argentina, C1131ACG Principal Investigator: Maria R Bologna          Hospital Ramos Mejía Recruiting Buenos Aires, Argentina, C1221ADC DF Principal Investigator: Irene Foradori          Fundacion Huesped Recruiting Buenos Aires, Argentina Principal Investigator: Pedro Cahn          Thailand Siriraj Hospital Mahidol University Recruiting Bangkok, Krung Thep Maha Nakhon, Thailand Principal Investigator: Kulkanya Chokephaibulkit          The HIV NAT Research Collaboration Recruiting Bangkok, Krung Thep Maha Nakhon, Thailand Principal Investigator: Sivaporn Getechompol          Srinagarind Hospital Khon Kaen University Recruiting Khon Kaen, Thailand Principal Investigator: Pope Kosalaraksa 收起 <<
NCT00445146 HIV Infections Phase 2 Completed - -

Delavirdine/地拉韦啶 参考文献

[1]Voorman RL, Payne NA, et al. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6. Drug Metab Dispos. 2001 Jan;29(1):41-7.

[2]Dueweke TJ, Poppe SM, et al. U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother. 1993 May;37(5):1127-31.

Delavirdine/地拉韦啶 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.95mL

2.19mL

1.10mL

21.90mL

4.38mL

2.19mL

Delavirdine/地拉韦啶 技术信息

CAS号136817-59-9
分子式C22H28N6O3S
分子量 456.56
SMILES Code CS(=O)(NC1=CC2=C(NC(C(N3CCN(C4=NC=CC=C4NC(C)C)CC3)=O)=C2)C=C1)=O
MDL No. MFCD00871405
别名 U 90152; BHAP-U 90152
运输蓝冰
InChI Key WHBIGIKBNXZKFE-UHFFFAOYSA-N
Pubchem ID 5625
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C

Tags: Delavirdine | 136817-59-9 | U 90152 | BHAP-U 90152 | U90152 | U-90152 | Anti-infection | HIV | Reverse Transcriptase | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Delavirdine/地拉韦啶 纯度/质量文件 | Delavirdine/地拉韦啶 生物活性 | Delavirdine/地拉韦啶 临床数据 | Delavirdine/地拉韦啶 参考文献 | Delavirdine/地拉韦啶 实验方案 | Delavirdine/地拉韦啶 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z